Literature DB >> 14666016

Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension.

Pierre Wauthy1, Sophia Abdel Kafi, Wolter J Mooi, Robert Naeije, Serge Brimioulle.   

Abstract

OBJECTIVE: Cardiac surgery for congenital heart defects is commonly complicated by shunt-induced chronic pulmonary hypertension and associated acute hypertensive crises. To investigate the effects of vasodilators in chronic and acute pulmonary hypertension, we used the innominate artery to create a growing aortopulmonary shunt in young piglets.
METHODS: Pulmonary hemodynamics and right ventricular function and their responses to hypoxia, intravenous prostacyclin, and inhaled nitric oxide were investigated after closure of the shunt by using pulmonary flow-pressure relationships, pulmonary vascular resistance partitioning, pulmonary vascular impedance, and ventriculoarterial coupling expressed as the ratio of right ventricular end-systolic elastance to effective pulmonary arterial elastance.
RESULTS: Shunt-induced pulmonary hypertension was associated with medial hypertrophy of pulmonary arteries, increased resistance, increased elastance, increased wave reflection, and preserved ventriculoarterial coupling. Hypoxic pulmonary vasoconstriction was blunted in the shunt group. Compared with prostacyclin, inhaled nitric oxide was a more effective vasodilator in the shunt group and in hypoxia. Effective pulmonary arterial elastance and right ventricular end-systolic elastance increased in chronic (shunt) and acute (hypoxic) hypertension and decreased with vasodilators, preserving a normal coupling.
CONCLUSIONS: A growing aortopulmonary shunt in the young pig is a reliable model of chronic pulmonary hypertension, with medial hypertrophy, increased resistance, and increased elastance. In this model inhaled nitric oxide is a better pulmonary vasodilator than intravenous prostacyclin, with neither drug having a specific inotropic effect, and normal coupling is preserved in chronic and acute pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666016     DOI: 10.1016/s0022-5223(03)01183-8

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

Review 1.  Biomechanics of the right ventricle in health and disease (2013 Grover Conference series).

Authors:  Robert Naeije; Serge Brimioulle; Laurence Dewachter
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

2.  Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase.

Authors:  Anna Klinke; Eva Berghausen; Kai Friedrichs; Simon Molz; Denise Lau; Lisa Remane; Matthias Berlin; Charlotte Kaltwasser; Matti Adam; Dennis Mehrkens; Martin Mollenhauer; Kashish Manchanda; Thorben Ravekes; Gustavo A Heresi; Metin Aytekin; Raed A Dweik; Jan K Hennigs; Lukas Kubala; Erik Michaëlsson; Stephan Rosenkranz; Tanja K Rudolph; Stanley L Hazen; Hans Klose; Ralph T Schermuly; Volker Rudolph; Stephan Baldus
Journal:  JCI Insight       Date:  2018-06-07

3.  Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops.

Authors:  Diana M Tabima; Timothy A Hacker; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

4.  Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study.

Authors:  Adriana Pavelescu; Robert Naeije
Journal:  Eur J Appl Physiol       Date:  2011-07-23       Impact factor: 3.078

5.  Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility.

Authors:  Steffen Rex; Carlo Missant; Patrick Segers; Rolf Rossaint; Patrick F Wouters
Journal:  Intensive Care Med       Date:  2007-08-21       Impact factor: 17.440

6.  Comparison of 3 methods to induce acute pulmonary hypertension in pigs.

Authors:  Anna B Roehl; Paul Steendijk; Jan H Baumert; Joerg Schnoor; Rolf Rossaint; Marc Hein
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

7.  Iloprost improves ventricular function in the hypertrophic and functionally impaired right heart by direct stimulation.

Authors:  Sarah Holmboe; Asger Andersen; Mads D Vildbrad; Jan M Nielsen; Steffen Ringgaard; Jens E Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 8.  Pulmonary vascular stiffness: measurement, modeling, and implications in normal and hypertensive pulmonary circulations.

Authors:  Kendall S Hunter; Steven R Lammers; Robin Shandas
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

9.  Comparison of the effectiveness of oral sildenafil versus oxygen administration as a test for feasibility of operation for patients with secondary pulmonary arterial hypertension.

Authors:  Gholam Hossein Ajami; Mohammad Borzoee; Mohammad Radvar; Hamid Amoozgar
Journal:  Pediatr Cardiol       Date:  2007-12-04       Impact factor: 1.655

10.  Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension.

Authors:  Steffen Rex; Carlo Missant; Piet Claus; Wolfgang Buhre; Patrick F Wouters
Journal:  Crit Care       Date:  2008-09-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.